FRONTEO, Inc. engages in the provision of computer forensic investigation services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 206 full-time employees. The company went IPO on 2007-06-26. The company operates through three segments. The Life Science AI segment develops AI-based drug discovery support platforms, medical literature search AI systems, and AI medical devices. The Risk Management segment provides comprehensive support for client risks from a holistic optimization perspective. The Digital Transformation (DX) segment provides support in the area of DX solutions for the manufacturing industry.